Dirk Lievens

3.5k citations

22 papers · 2.3k indexed · h-index 19

Impact in

Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
- Immune Response and Inflammation
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research

Papers in

Immunology and Allergy 13
- Cell Adhesion Molecules Research 13
Immunology 15
- Atherosclerosis and Cardiovascular Diseases 12
- Immune cells in cancer 3
- Immune Response and Inflammation 2
- T-cell and B-cell Immunology 2

Co-authors: Esther Lutgens Philipp von Hundelshausen Christian Weber Mat J.A.P. Daemen Oliver Soehnlein Linda Beckers Alma Zernecke Maik Drechsler
Journals: Arteriosclerosis Thrombosis and Vascular Biology (4 papers)Blood (3 papers)Thrombosis and Haemostasis (2 papers)Circulation (2 papers)Circulation Research (2 papers)
Partner nations: Germany Netherlands United States

In The Last Decade

Dirk Lievens

21 papers receiving 2.2k citations

Peers

Countries citing papers authored by Dirk Lievens

Since Specialization

Citations

This map shows the geographic impact of Dirk Lievens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Lievens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Lievens more than expected).

Fields of papers citing papers by Dirk Lievens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Lievens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Lievens. The network helps show where Dirk Lievens may publish in the future.

Co-authors

The 25 scholars most cited alongside Dirk Lievens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk Lievens Line = papers co-authored together Dirk Lievens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD40L Deficiency Protects Against Aneurysm Formation Arteriosclerosis Thrombosis and Vascular Biology ·Pascal Kusters, Tom Seijkens, Linda Beckers, Dirk Lievens, Holger Winkels, Vivian de Waard, Adriaan Duijvestijn, Moritz Lindquist Liljeqvist, Joy Roy, Alan Daugherty, Andrew C. Newby, Norbert Gerdes, Esther Lutgens	2018	18
2	Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes Arteriosclerosis Thrombosis and Vascular Biology ·Norbert Gerdes, Tom Seijkens, Dirk Lievens, Marijke J. E. Kuijpers, Holger Winkels, Delia Projahn, Helene Hartwig, Linda Beckers, Remco T. A. Megens, Louis Boon, Randolph J. Noelle, Oliver Soehnlein, Johan W. M. Heemskerk, Christian Weber, Esther Lutgens	2016	94
3	Immune-mediated and lipid-mediated platelet function in atherosclerosis Current Opinion in Lipidology ·Maiwand Ahmadsei, Dirk Lievens, Christian Weber, Philipp von Hundelshausen, Norbert Gerdes	2015	13
4	Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α Arteriosclerosis Thrombosis and Vascular Biology ·Marijke J. E. Kuijpers, Nadine J.A. Mattheij, Lina Cipolla, Johanna P. van Geffen, Toby Lawrence, Marjo M. P. C. Donners, Louis Boon, Dirk Lievens, Mauro Torti, Heidi Noels, Norbert Gerdes, Judith M.E.M. Cosemans, Esther Lutgens, Johan W. M. Heemskerk	2015	30
5	Deficiency of the Sialyltransferase St3Gal4 Reduces Ccl5-Mediated Myeloid Cell Recruitment and Arrest Circulation Research ·Yvonne Döring, Heidi Noels, Manuela Mandl, Birgit K. Kramp, Carlos Neideck, Dirk Lievens, Maik Drechsler, Remco T. A. Megens, Pathricia V. Tilstam, Anura Don, Helene Hartwig, Wendy Theelen, Jamey D. Marth, Markus Sperandio, Oliver Soehnlein, Christian Weber	2014	47
6	Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes EMBO Molecular Medicine ·Oliver Soehnlein, Maik Drechsler, Yvonne Döring, Dirk Lievens, Helene Hartwig, Reem Shomakhy, Almudena Ortega‐Gómez, Manuela Mandl, Santosh Vijayan, Delia Projahn, Christoph D. Garlichs, Rory R. Koenen, Mihail Hristov, Esther Lutgens, Alma Zernecke, Christian Weber	2013	164
7	Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice Circulation Research ·Yvonne Döring, Maik Drechsler, 和寿原田, Reem Shomakhy, Dirk Lievens, Santosh Vijayan, Richard L. Gallo, Christian Weber, Oliver Soehnlein	2012	168
8	Contribution of Platelet CX ₃ CR1 to Platelet–Monocyte Complex Formation and Vascular Recruitment During Hyperlipidemia Arteriosclerosis Thrombosis and Vascular Biology ·Otilia Postea, Elena M. Vasina, Sandra Cauwenberghs, Delia Projahn, Elisa A. Liehn, Dirk Lievens, Wendy Theelen, Birgit K. Kramp, Elena Butoi, Oliver Soehnlein, Johan W. M. Heemskerk, Andreas Ludwig, Christian Weber, Rory R. Koenen	2012	70
9	Chemokine receptor axes sequentially control the prominent proatherogenic function of classical monocytes Journal of Vascular Research ·Maik Drechsler, Oliver Soehnlein, P.J. Lewin, Santosh Vijayan, Dirk Lievens, Helene Hartwig, Mihail Hristov, Esther Lutgens, Alma Zernecke, Christian Weber	2011	0
10	Platelets in atherosclerosis Thrombosis and Haemostasis ·Philipp von Hundelshausen, Dirk Lievens	2011	205
11	Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile The Journal of Experimental Medicine ·Esther Lutgens, Dirk Lievens, Linda Beckers, Erwin Wijnands, Oliver Soehnlein, Alma Zernecke, Tom Seijkens, David Engel, Jack P.M. Cleutjens, Anna M. Keller, Shalin H. Naik, Louis Boon, Hafid Ait‐Oufella, Ziad Mallat, Cory L. Ahonen, Randolph J. Noelle, Menno P.J. de Winther, Mat J.A.P. Daemen, Erik A.L. Biessen, Christian Weber	2010	197
12	Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis Blood ·Dirk Lievens, Alma Zernecke, Tom Seijkens, Oliver Soehnlein, Linda Beckers, Imke C.A. Munnix, Erwin Wijnands, Pieter Goossens, Roger van Kruchten, B. Thülig, Louis Boon, Richard A. Flavell, Randolph J. Noelle, Norbert Gerdes, Erik A.L. Biessen, Mat J.A.P. Daemen, Johan W. M. Heemskerk, Christian Weber, Esther Lutgens	2010	237
13	Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6 Blood ·Sonja Loges, Thomas Schmidt, Marc Tjwa, Katie Van Geyte, Dirk Lievens, Esther Lutgens, Davy Vanhoutte, Delphine Borgel, Stéphane Plaisance, Marc Hoylaerts, Aernout Luttun, Mieke Dewerchin, Bart Jonckx, Peter Carmeliet	2009	137
14	Serotonin stimulates platelet receptor shedding by tumor necrosis factor‐alpha‐converting enzyme (ADAM17) Journal of Thrombosis and Haemostasis ·Daniel Duerschmied, Matthias Canault, Dirk Lievens, Alexander Brill, Stephen M. Cifuni, Michael Bäder, Denisa D. Wagner	2009	37
15	The immunobiology of CD154–CD40–TRAF interactions in atherosclerosis Seminars in Immunology ·David Engel, Tom Seijkens, Marjorie Poggi, Micaela Nicole, B. Thülig, Linda Beckers, Erwin Wijnands, Dirk Lievens, Esther Lutgens	2009	56
16	The multi-functionality of CD40L and its receptor CD40 in atherosclerosis Thrombosis and Haemostasis ·Dirk Lievens, Wouter Eijgelaar, Erik A.L. Biessen, Mat J.A.P. Daemen, Esther Lutgens	2009	99
17	The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling Blood ·Marjo M. P. C. Donners, Linda Beckers, Dirk Lievens, Imke C.A. Munnix, Johan W. M. Heemskerk, Ben Janssen, Erwin Wijnands, Jack P.M. Cleutjens, Alma Zernecke, Christian Weber, Cory L. Ahonen, Ulrike Benbow, Andrew C. Newby, Randolph J. Noelle, Mat J.A.P. Daemen, Esther Lutgens	2008	69
18	Platelet CD40L: a powerful leukocyte and endothelial cell activator in atherosclerosis Circulation ·Dirk Lievens, Alma Zernecke, Jana Bečvářová, Linda Beckers, Erwin Wijnands, Maaike Mulder-Nijkamp, Johan W. M. Heemskerk, Christian Weber, Mat J.A.P. Daemen, Esther Lutgens	2007	2
19	CD40 and Its Ligand in Atherosclerosis Trends in Cardiovascular Medicine ·Esther Lutgens, Dirk Lievens, Linda Beckers, Marjo M. P. C. Donners, Mat J.A.P. Daemen	2007	93
20	Screening for Insulitis in Adult Autoantibody-Positive Organ Donors Diabetes ·Pieter In 'T Veld, Dirk Lievens, Ingrid Lempp, Zhidong Ling, Bart Van Der Auwera, Miriam Pipeleers‐Marichal, Frans Gorus, Daniël Pipeleers	2007	138

About Dirk Lievens

Dirk Lievens is a scholar working on Immunology and Allergy, Immunology, Hematology, Oncology and Cancer Research, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (13 papers), Atherosclerosis and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (6 papers), Chemokine receptors and signaling (6 papers), Immune cells in cancer (3 papers), Immune Response and Inflammation (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (1.4k citations), Immunology and Allergy (300 citations), Hematology (329 citations), Internal Medicine (72 citations) and Cancer Research (205 citations). Dirk Lievens has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Esther Lutgens, Philipp von Hundelshausen, Christian Weber, Mat J.A.P. Daemen, Oliver Soehnlein, Linda Beckers, Alma Zernecke, Maik Drechsler, Yvonne Döring and Erik A.L. Biessen. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Blood, Thrombosis and Haemostasis, Circulation and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact